Skip to content

EBITDA margin at other companies

Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
8.5%+0.6pp
Herbalife logo
HerbalifeHLF
12%+0.7pp
BellRing Brands logo
BellRing BrandsBRBR
13.3%-7.3pp
United Natural Foods logo
United Natural FoodsUNFI
1.2%0.0pp
US Foods logo
US FoodsUSFD
4.2%0.0pp
Universal Corporation logo
Universal CorporationUVV
8.2%-1.8pp

Other financials

Income statement

See full
Revenue$250.2M+0.3%
Gross profit$190.8M-3.2%
Operating income$13.9M-11.5%
Net income$7.5M-20.1%
EPS (diluted)$0.41-16.3%

Balance sheet

See full
Cash & equivalents$165.7M-9.2%
Total debt$18.0M+10.8%
Total equity$543.6M+2.6%
Total assets$739.0M-1.0%

Cash flow

See full
Operating cash flow$9.8M-37.0%
CapEx$2.6M-5.6%
Free cash flow$7.1M-43.9%

Valuation

See full
Market cap$363.35M-36.1%
P/E18.1×+7.8×
P/S0.4×-0.3×

Profitability

See full
Gross margin77.6%-3.0pp
Operating margin3.8%-2.7pp
Net margin1.9%-4.4pp
FCF margin5.7%-1.1pp

Returns & leverage

See full
Return on equity3.2%-7.6pp
Debt / equity0.0×
Current ratio2.5×+0.5×

Where this comes from

Calculated from USANA Health Sciences’s reported figures.

Based on trailing twelve months.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is USANA Health Sciences's EBITDA margin?
USANA Health Sciences (USNA) reported EBITDA margin of 7.4% in Q1 2026.
How has USANA Health Sciences's EBITDA margin changed year-over-year?
USANA Health Sciences's EBITDA margin decreased by 16.3% year-over-year, from 8.8% to 7.4%.
What is the long-term trend for USANA Health Sciences's EBITDA margin?
Over 3 years (2022 to 2025), USANA Health Sciences's EBITDA margin has grown at a -14.5% compound annual growth rate (CAGR), from 12.1% to 7.6%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.